Published online March 1, 2007
PEDIATRICS Vol. 119 No. 3 March 2007, pp. 535-543 (doi:10.1542/peds.2006-2447)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freeman, J. M.
Right arrow Articles by Hartman, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freeman, J. M.
Right arrow Articles by Hartman, A. L.
Related Collections
Right arrow Nutrition & Metabolism

STATE-OF-THE-ART REVIEW ARTICLE

The Ketogenic Diet: One Decade Later

John M. Freeman, MD, Eric H. Kossoff, MD and Adam L. Hartman, MD

John M. Freeman Pediatric Epilepsy Center, Johns Hopkins Medical Institutions, Baltimore, Maryland

ABSTRACT

The ketogenic diet, a high fat, adequate protein, low carbohydrate diet, has, during the past decade, had a resurgence of interest for the treatment of difficult-to-control seizures in children. This review traces its history, reviews its uses and side effects, and discusses possible alternatives and the diet’s possible mechanisms of action. Finally, this review looks toward possible future uses of the ketogenic diet for conditions other than epilepsy.

Key Words: ketogenic diet • pediatric epilepsy • mechanisms of action

Abbreviations: KD—ketogenic diet • MCT—medium-chain triglyceride • LCT—long-chain triglyceride

Accepted Oct 18, 2006.




This article has been cited by other articles:


Home page
 J Child NeurolHome page
J. Nizamuddin, Z. Turner, J. E. Rubenstein, P. L. Pyzik, and E. H. Kossoff
Management and Risk Factors for Dyslipidemia With the Ketogenic Diet
J Child Neurol, July 1, 2008; 23(7): 758 - 761.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
N. Kuppermann, J. Park, K. Glatter, J. P. Marcin, and N. S. Glaser
Prolonged QT Interval Corrected for Heart Rate During Diabetic Ketoacidosis in Children
Arch Pediatr Adolesc Med, June 1, 2008; 162(6): 544 - 549.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
X.-Y. Lian, F. A. Khan, and J. L. Stringer
Fructose-1,6-Bisphosphate Has Anticonvulsant Activity in Models of Acute Seizures in Adult Rats
J. Neurosci., October 31, 2007; 27(44): 12007 - 12011.
[Abstract] [Full Text] [PDF]